Deep Track Capital’s Xenon Pharmaceuticals XENE Stock Holding History

Deep Track Capital’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-366,435	Closed	-$16.4M	–	69
2025 Q4	$16.4M	Sell	366,435 -833,565	-69%	-$35M	0.29%	43
2025 Q3	$48.2M	Sell	1,200,000 -150,000	-11%	-$5.28M	1.34%	27
2025 Q2	$42.3M	Buy	1,350,000 +350,000	+35%	+$11.4M	1.36%	23
2025 Q1	$33.5M	Buy	1,000,000 +830,868	+491%	+$31.5M	1.09%	26
2024 Q4	$6.63M	Buy	+169,132	New	+$6.99M	0.25%	53

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Deep Track Capital's XENE Position: Q1 2026 in Review

Deep Track Capital sold out of Xenon Pharmaceuticals (XENE) in Q1 2026, closing a stake of 366,435 shares — an estimated $16.4M sold.

Deep Track Capital first reported a position in XENE in Q4 2024 and held it in 5 quarters. The position peaked at $48.2M in Q3 2025. 290 funds tracked by Wall St. Rank hold XENE as of Q1 2026.

Deep Track Capital reported no remaining Xenon Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Deep Track Capital sold 366,435 Xenon Pharmaceuticals shares in Q1 2026, an estimated $16.4M.
Deep Track Capital first reported a position in Xenon Pharmaceuticals in Q4 2024 and held it in 5 quarters.
Deep Track Capital's Xenon Pharmaceuticals position peaked at $48.2M in Q3 2025.
290 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2026.

Based on Deep Track Capital's 13F filing for Q1 2026, filed 15 May 2026.